• 2935 Citations
  • 28 h-Index
20002019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 2935 Citations
  • 28 h-Index
  • 169 Article
  • 5 Letter
  • 3 Comment/debate
  • 2 Review article
Filter
Article
2019
2 Citations (Scopus)

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

Korean Multiple Myeloma Working Party, 2019 Jan 1, In : Japanese Journal of Clinical Oncology. 49, 1, p. 92-95 4 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis

on behalf of Aplastic Anemia Working Party of the Korean Society of Hematology, 2019 Oct 1, In : Annals of Hematology. 98, 10, p. 2273-2281 9 p.

Research output: Contribution to journalArticle

Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria

Sakurai, M., Jang, J. H., Chou, W. C., Kim, J. S., Wilson, A., Nishimura, J. I., Chiou, T. J., Kanakura, Y., Lee, J. W. & Okamoto, S., 2019 Oct 1, In : International Journal of Hematology. 110, 4, p. 411-418 8 p.

Research output: Contribution to journalArticle

Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/−DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia

Jang, J. E., Hwang, D. Y., Chung, H., Kim, S. J., Eom, J. I., Jeung, H. K., Song, J., Kim, J. S., Cheong, J. W. & Min, Y. H., 2019 Oct, In : Biology of Blood and Marrow Transplantation. 25, 10, p. 2070-2078 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: Consortium for improving survival of lymphoma (CISL) study

Oh, S. Y., Kim, W. S., Kim, J. S., Kim, S. J., Yoon, D. H., Yang, D. H., Lee, W. S., Kim, H. J., Yhim, H. Y., Jeong, S. H., Won, J. H., Lee, S., Kong, J. H., Lim, S. N., Ji, J. H., Kwon, K. A., Lee, G. W., Lee, J. H., Lee, H. S., Shin, H. J. & 1 others, Suh, C., 2019 Oct 16, In : Cancer Communications. 39, 1, 58.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)

Yoon, J. H., Yoo, K. H., Sung, K. W., Jung, C. W., Kim, J. S., Hahn, S. M., Kang, H. J., Lee, J. H., Im, H. J., Ahn, J. S., Kook, H., Cho, B. & Lee, J. W., 2019 Aug 1, In : Bone Marrow Transplantation. 54, 8, p. 1361-1368 8 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

Korean Multiple Myeloma 151 Investigators, 2019 Jan 22, In : International Journal of Hematology. 109, 1, p. 79-90 12 p.

Research output: Contribution to journalArticle

2018

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis

Hong, J. Y., Yoon, D. H., Suh, C., Kim, W. S., Kim, S. J., Jo, J. C., Kim, J., Lee, W. S., Oh, S. Y., Park, Y., Kim, S. Y., Lee, M. H., Lee, H. S. & Do, Y. R., 2018 Aug 1, In : Annals of Hematology. 97, 8, p. 1437-1443 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial

Ogura, M., Sancho, J. M., Cho, S. G., Nakazawa, H., Suzumiya, J., Tumyan, G., Kim, J., Lennard, A., Mariz, J., Ilyin, N., Jurczak, W., Lopez Martinez, A., Samoilova, O., Zhavrid, E., Yañez Ruiz, E., Trneny, M., Popplewell, L., Coiffier, B., Buske, C., Kim, W. S. & 4 others, Lee, S. J., Lee, S. Y., Bae, Y. J. & Kwak, L. W., 2018 Nov 1, In : The Lancet Haematology. 5, 11, p. e543-e553

Research output: Contribution to journalArticle

14 Citations (Scopus)

HBsAg-negative, anti-hbc-negative patients still have a risk of hepatitis b virus-related hepatitis after autologous stem cell transplantation for multiple myeloma or malignant lymphoma

Park, H., Kim, D. Y., Kim, S. J., Chung, H., Cho, H., Jang, J. E., Cheong, J. W., Min, Y. H., Song, J. W. & Kim, J. S., 2018 Oct 1, In : Cancer Research and Treatment. 50, 4, p. 1121-1129 9 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
3 Citations (Scopus)

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy

Cho, H., Yoon, D. H., Kim, K. P., Bae, K. S., Kim, W. S., Eom, H. S., Kim, J., Hong, J. Y., Kim, S. J., Lee, H., Kim, S. J. & Suh, C., 2018 Oct 1, In : Investigational New Drugs. 36, 5, p. 877-885 9 p.

Research output: Contribution to journalArticle

Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study

Yoo, K. H., Kang, D., Kim, I. R., Choi, E. K., Kim, J. S., Yoon, S. S., Lee, C. H., Park, S., Kim, S. J., Kim, K., Kim, W. S., Jung, C. W., Choi, H. J., Jang, J. H. & Cho, J., 2018 Aug 1, In : Bone Marrow Transplantation. 53, 8, p. 967-976 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

'Screening audit' as a quality assurance tool in good clinical practice compliant research environments

Park, S., Nam, C. M., Park, S., Noh, Y. H., Ahn, C. R., Yu, W. S., Kim, B. K., Kim, S. M., Kim, J. S. & Rha, S. Y., 2018 Apr 25, In : BMC Medical Ethics. 19, 1, 30.

Research output: Contribution to journalArticle

The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in transplantation ineligible patients with multiple myeloma

Lee, G. W., Park, S. W., Go, S. I., Kim, H. G., Kim, M. K., Min, C. K., Kwak, J. Y., Bae, S. B., Yoon, S. S., Lee, J. J., Kim, K. H., Nam, S. H., Mun, Y. C., Kim, H. J., Bae, S. H., Shin, H. J., Lee, J. H., Park, J. S., Jeong, S. H., Lee, M. H. & 26 others, Lee, H. S., Park, K. W., Lee, W. S., Lee, S. M., Lee, J. O., Hyun, M. S., Jo, D. Y., Lim, S. N., Lee, J. H., Kim, H., Cho, D. Y., Do, Y. R., Kim, J. A., Park, S. K., Kim, J. S., Kim, S. J., Yi, H. G., Moon, J. H., Choi, C. W., Kim, S. H., Kim, B. S., Park, M. R., Shim, H., Song, M. K., Kim, Y. & Kim, K., 2018 Oct 1, In : Acta Haematologica. 140, 3, p. 146-156 11 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2017

AMPK-ULK1-mediated autophagy confers resistance to BET inhibitor JQ1 in acute myeloid leukemia stem cells

Jang, J. E., Eom, J. I., Jeung, H. K., Cheong, J. W., Lee, J. Y., Kim, J. S. & Min, Y. H., 2017 Jun 1, In : Clinical Cancer Research. 23, 11, p. 2781-2794 14 p.

Research output: Contribution to journalArticle

29 Citations (Scopus)

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalanprednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

Kim, M. K., Kim, K., Min, C. K., Kwak, J. Y., Bae, S. B., Yoon, S. S., Lee, J. J., Kim, K. H., Nam, S. H., Mun, Y. C., Kim, H. J., Bae, S. H., Shin, H. J., Lee, J. H., Park, J. S., Jeong, S. H., Lee, M. H., Kim, Y. S., Lee, H. S., Park, K. W. & 24 others, Lee, W. S., Lee, S. M., Lee, J. O., Hyun, M. S., Jo, D. Y., Lim, S. N., Lee, J. H., Cho, D. Y., Do, Y. R., Kim, J. A., Park, S. K., Kim, J. S., Kim, S. J., Kim, H., Yi, H. G., Moon, J. H., Choi, C. W., Kim, S. H., Joo, Y. D., Kim, H. G., Kim, B. S., Park, M. R., Song, M. K. & Kim, S. Y., 2017 Jan 1, In : Oncotarget. 8, 23, p. 37605-37618 14 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: A single-institution experience

Lee, J. Y., Chung, H., Cho, H., Jang, J. E., Kim, Y., Kim, S. J., Kim, J. S., Hyun, S. Y., Min, Y. H. & Cheong, J. W., 2017 Jan 1, In : Blood Research. 52, 3, p. 184-192 9 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma

Kim, Y., Kim, S. J., Cheong, J. W., Cho, H., Chung, H., Lee, J. Y., Jang, J. E., Min, Y. H. & Kim, J. S., 2017 Dec, In : Hematological Oncology. 35, 4, p. 465-471 7 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores

Lee, H., Kim, Y. R., Kim, S. J., Park, Y., Eom, H. S., Oh, S. Y., Kim, H. J., Kang, H. J., Lee, W. S., Moon, J. H., Won, Y. W., Kim, T. S. & Kim, J. S., 2017 Nov 1, In : Annals of Hematology. 96, 11, p. 1873-1881 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy

and the Korean Multiple Myeloma Working Party, 2017 Dec, In : American Journal of Hematology. 92, 12, p. 1280-1286 7 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Decitabine as a first-line treatment for older adults newly diagnosed with acute myeloid leukemia

Park, H., Chung, H., Lee, J., Jang, J., Kim, Y., Kim, S. J., Kim, J. S., Min, Y. H. & Cheong, J. W., 2017 Jan, In : Yonsei medical journal. 58, 1, p. 35-42 8 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial

Kim, W. S., Buske, C., Ogura, M., Jurczak, W., Sancho, J. M., Zhavrid, E., Kim, J. S., Hernández-Rivas, J. Á., Prokharau, A., Vasilica, M., Nagarkar, R., Osmanov, D., Kwak, L. W., Lee, S. J., Lee, S. Y., Bae, Y. J. & Coiffier, B., 2017 Aug, In : The Lancet Haematology. 4, 8, p. e362-e373

Research output: Contribution to journalArticle

39 Citations (Scopus)

Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: Prospective study of a Korean PNH cohort

Choi, C. W., Jang, J. H., Kim, J. S., Jo, D. Y., Lee, J. H., Kim, S. H., Kim, Y. K., Won, J. H., Chung, J. S., Kim, H., Lee, J. H., Kim, M. K., Eom, H. S., Hyun, S. Y., Kim, J. A. & Lee, J. W., 2017 Jan 1, In : Blood Research. 52, 3, p. 207-211 5 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of “RISK” Study

Choi, J. K., Cho, S. Y., Yoon, S. S., Moon, J. H., Kim, S. H., Lee, J. H., Kim, J. S., Cheong, J. W., Jang, J. H., Seo, B. J., Kim, Y. J., Lee, H. J., Lee, J., Lee, J. W. & Lee, D. G., 2017 Oct, In : Biology of Blood and Marrow Transplantation. 23, 10, p. 1773-1779 7 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation

Byun, H. K., Yoon, H. I., Cho, J., Kim, H. J., Min, Y. H., Lyu, C. J., Cheong, J. W., Kim, J. S., Kim, H. S., Kim, S. J., Yang, A. J., Lee, B. M., Lee, W. H., Lee, J., Ahn, K. J. & Suh, C. O., 2017 Sep, In : Radiation Oncology Journal. 35, 3, p. 257-267 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Improved prognostic stratification using NCCN- and GELTAMOinternational prognostic index in patients with diffuse large B-cell lymphoma

Hong, J., Kim, S. J., Chang, M. H., Kim, J. A., Kwak, J. Y., Kim, J. S., Yoon, D. H., Lee, W. S., Do, Y. R., Kang, H. J., Eom, H. S., Park, Y., Won, J. H., Mun, Y. C., Kim, H. J., Kwon, J. H., Kong, J. H., Oh, S. Y., Lee, S., Bae, S. H. & 10 others, Yang, D. H., Jun, H. J., Lee, H. S., Yun, H. J., Lee, S. I., Kim, M. K., Yi, J. H., Lee, J. H., Kim, W. S. & Suh, C., 2017 Jan 1, In : Oncotarget. 8, 54, p. 92171-92182 12 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Long-term follow-up of patients after autologous bone marrow cell infusion for decompensated liver cirrhosis

Kim, J. K., Kim, S. J., Kim, Y., Chung, Y. E., Park, Y. N., Kim, H. O., Kim, J. S., Park, M. S., Sakaida, I., Kim, D. Y., Lee, J. I., Ahn, S. H., Lee, K. S. & Han, K. H., 2017 Jan 1, In : Cell transplantation. 26, 6, p. 1059-1066 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study

Kumar, S. K., Dimopoulos, M. A., Kastritis, E., Terpos, E., Nahi, H., Goldschmidt, H., Hillengass, J., Leleu, X., Beksac, M., Alsina, M., Oriol, A., Cavo, M., Ocio, E. M., Mateos, M. V., O'Donnell, E. K., Vij, R., Lokhorst, H. M., Van De Donk, N. W. C. J., Min, C., Mark, T. & 27 others, Turesson, I., Hansson, M., Ludwig, H., Jagannath, S., Delforge, M., Kyriakou, C., Hari, P., Mellqvist, U., Usmani, S. Z., Dytfeld, D., Badros, A. Z., Moreau, P., Kim, K., Otero, P. R., Lee, J. H., Shustik, C., Waller, D., Chng, W. J., Ozaki, S., Lee, J. J., De La Rubia, J., Eom, H. S., Rosinol, L., Lahuerta, J. J., Sureda, A., Kim, J. S. & Durie, B. G. M., 2017 Nov 1, In : Leukemia. 31, 11, p. 2443-2448 6 p.

Research output: Contribution to journalArticle

72 Citations (Scopus)

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial

Seo, J., Kim, W. S., Kim, J. S., Kim, S. J., Lee, J. H., Hong, J. S., Lee, G. W., Oh, S. Y., Lee, J. H., Yoon, D. H., Lee, W. S., Kim, H. J., Kwak, J. Y., Kang, H. J., Jo, J. C., Park, Y., Lee, H. S., Kim, H. J. & Suh, C., 2017 Jan 1, In : Blood Research. 52, 3, p. 200-206 7 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma

Kim, Y. R., Kim, S. J., Cheong, J. W., Chung, H., Jang, J. E., Kim, Y., Yang, W. I., Min, Y. H. & Kim, J. S., 2017 Jan 1, In : Oncotarget. 8, 54, p. 92312-92323 12 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Prognostic significance of interventricular septal thickness in patients with AL amyloidosis

Cho, H., Kim, S. J., Shim, C. Y., Hong, G. R., Ha, J. W., Kim, Y. R., Yang, W. I., Chung, H., Jang, J. E., Cheong, J. W., Min, Y. H. & Kim, J. S., 2017 Sep, In : Leukemia Research. 60, p. 36-43 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma

Cho, H., Kim, S. H., Kim, S. J., Chang, J. H., Yang, W. I., Suh, C. O., Kim, Y. R., Jang, J. E., Cheong, J. W., Min, Y. H. & Kim, J. S., 2017 Jan 1, In : Oncotarget. 8, 50, p. 87317-87328 12 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma

Cho, H., Kim, S., Kim, S. J., Chang, J. H., Yang, W. I., Suh, C-O., Cheong, J. W., Kim, Y. R., Lee, J. Y., Jang, J. E., Kim, Y., Min, Y. H. & Kim, J., 2017 Jul 1, In : Annals of Hematology. 96, 7, p. 1163-1173 11 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: A retrospective multicenter study (KMM160)

Korean Multiple Myeloma Working Party, 2017 Jan 1, In : Oncotarget. 8, 45, p. 79517-79526 10 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2016

A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma

Jang, J. E., Kim, Y. R., Kim, S. J., Cho, H., Chung, H., Lee, J. Y., Park, H., Kim, Y., Cheong, J. W., Min, Y. H. & Kim, J., 2016 Apr 1, In : European Journal of Cancer. 57, p. 127-135 9 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas

Kim, S. J., Shin, D. Y., Kim, J. S., Yoon, D. H., Lee, W. S., Lee, H., Do, Y. R., Kang, H. J., Eom, H. S., Ko, Y. H., Lee, S. H., Yoo, H. Y., Hong, M., Suh, C. & Kim, W. S., 2016 Apr 1, In : Annals of Oncology. 27, 4, p. 712-718 7 p., mdv624.

Research output: Contribution to journalArticle

16 Citations (Scopus)

A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial

Oh, S. Y., Kim, W. S., Kim, J. S., Chae, Y. S., Lee, G. W., Eom, H. S., Ryoo, H. M., Lee, S., Kim, S. J., Yoon, D. H., Won, J. H., Hong, J., Park, J., Lee, S. M., Hong, J. Y., Park, E., Kim, H. J., Yang, D. H., Kim, H. J. & Suh, C., 2016 Jun 2, In : Leukemia and Lymphoma. 57, 6, p. 1406-1412 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: A multicentre, retrospective analysis

Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D. Y., Kim, J., Jeong, S. H., Yang, D. H., Jo, J. C., Lee, G. W., Choi, C. W., Lee, W. S., Chen, T. Y., Kim, K. & 11 others, Jung, S. H., Murayama, T., Oki, Y., Advani, R., d'Amore, F., Schmitz, N., Suh, C., Suzuki, R., Kwong, Y. L., Lin, T. Y. & Kim, W. S., 2016 Mar 1, In : The Lancet Oncology. 17, 3, p. 389-400 12 p.

Research output: Contribution to journalArticle

93 Citations (Scopus)

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party

On behalf of the Korean Multiple Myeloma Working Party, 2016 Jan 1, In : Blood Research. 51, 3, p. 193-199 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea

Cheong, H. I., Jo, S. K., Yoon, S. S., Cho, H., Kim, J. S., Kim, Y. O., Koo, J. R., Park, Y., Park, Y. S., Shin, J. I., Yoo, K. H. & Oh, D., 2016 Jan 1, In : Journal of Korean medical science. 31, 10, p. 1516-1528 13 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry

Kim, J. S., Jang, J. H., Yoon, S. S., Lee, J. H., Kim, Y. K., Jo, D. Y., Chung, J. S., Sohn, S. K. & Lee, J. W., 2016 Jan 1, In : Annals of Hematology. 95, 1, p. 125-133 9 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study

Jeong, S. H., Kim, D. Y., Jang, J. H., Mun, Y. C., Choi, C. W., Kim, S. H., Kim, J. S. & Park, J. S., 2016 Jan 1, In : Annals of Hematology. 95, 2, p. 337-344 8 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: A previously unrecognized serious adverse event in a pilot study with romidepsin

Kim, W. S., Kim, J. H., Ki, C. S., Ko, Y. H., Kim, J. S. & Kim, W. S., 2016 Mar 1, In : Annals of Oncology. 27, 3, p. 508-513 6 p., mdv596.

Research output: Contribution to journalArticle

26 Citations (Scopus)

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study

Kim, S. J., Hong, J. S., Chang, M. H., Kim, J. A., Kwak, J. Y., Kim, J. S., Yoon, D. H., Lee, W. S., Do, Y. R., Kang, H. J., Eom, H. S., Park, Y., Won, J. H., Mun, Y. C., Kim, H. J., Kwon, J. H., Kong, J. H., Oh, S. Y., Lee, S., Bae, S. H. & 9 others, Yang, D. H., Jun, H. J., Kim, Y. S., Yun, H. J., Lee, S. I., Kim, M. K., Park, E. K., Kim, W. S. & Suh, C., 2016 Jan 1, In : Oncotarget. 7, 44, p. 72033-72043 11 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma

Hwang, D. Y., Kim, S. J., Cheong, J. W., Kim, Y., Jang, J. E., Lee, J. Y., Min, Y. H., Yang, W. I. & Kim, J., 2016 Jan 2, In : Leukemia and Lymphoma. 57, 1, p. 51-57 7 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosomepositive acute lymphoblastic leukemia

Yoon, J. H., Yhim, H. Y., Kwak, J. Y., Ahn, J. S., Yang, D. H., Lee, J. J., Kim, S. J., Kim, J., Park, S. J., Choi, C. W., Eom, H. S., Park, S. K., Choi, S. Y., Kim, S. H., Kim, D. W. & Lee, S., 2016 Jun 18, In : Annals of Oncology. 27, 6, p. 1081-1088 8 p., mdw123.

Research output: Contribution to journalArticle

17 Citations (Scopus)

Predictive factors of mortality in population of patients with paroxysmal nocturnal hemoglobinuria (PNH): Results from a Korean PNH registry

Jang, J. H., Kim, J. S., Yoon, S. S., Lee, J. H., Kim, Y. K., Jo, D. Y., Chung, J., Sohn, S. K. & Lee, J. W., 2016 Jan 1, In : Journal of Korean medical science. 31, 2, p. 214-221 8 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)